Stem cell Therapy Market to surpass US$ 33.6 Billion by 2026 - Coherent Market Insights

The Global Stem Cell Therapy Market, by Source (Embryonic Cells, Adult Stem Cells, Mesenchymal Stem Cells, and Induced Pluripotent Stem Cells) by Therapy Type (Allogeneic Stem Cell Therapy, and Autologous Stem cell Therapy), by Application (Gastro-Intestine Diseases, Central Nervous Diseases, Cardiovascular Diseases, Wounds and Injuries, Eye Diseases, Immune Therapy Diseases, and Musculoskeletal Disorders, and Others), by End User (Hospitals and Clinics, and Ambulatory Surgical  Centers) by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 7,342.0 million in 2018, and is projected to exhibit a CAGR of 21.0%, during the forecast period (2018 - 2026), as highlighted in a new report published by Coherent Market Insights.

Stem cell banks facilitate extraction, processing of stem cells, and storage of stem cells for future use. Increasing launches of stem cell banks is expected to boost the stem cell therapy market growth. For instance, in January 2018, Lifecell Biotechnology launched a stem cell bank in India, which preserves and provides umbilical cord stem cells for stem cell transplantation. In a stem cell transplantation therapy damaged, diseased cell or tissues are replaced or repaired by using stem cells. Hence, stem cell banking is expected to support the stem cell therapy market growth.

Increasing number of approvals from regulatory authorities are expected to drive growth of the global stem cell therapy market. For instance, in March 2018, TiGenix NV and Takeda Pharmaceuticals received central marketing authorization from the European Commission to market Alofisel (an allogeneic stem cell therapy) in Europe. This therapy is used for the treatment of complex perianal fistulas in adult patients.

Browse 23 Market Data Tables and 19 Figures spread through 157 Pages and in-depth TOC on "Stem Cell Therapy Market, by Source (Embryonic Cells, Adult Stem Cells, Mesenchymal Stem Cells, and Induced Pluripotent Stem Cells) by Therapy Type (Allogeneic Stem Cell Therapy, and Autologous Stem cell Therapy),by Application (Gastro-Intestine Diseases, Central Nervous Diseases, Cardiovascular Diseases, Wounds and Injuries, Eye Diseases, Immune Therapy Diseases, Musculoskeletal Disorders, and Others), by End User (Hospitals and Clinics, and Ambulatory Surgical  Centers), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"

To know the latest trends and insights related to Stem Cell Therapy Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/stem-cell-therapy-market-2848

Key players in the stem cell therapy market are focused on launching new products in order to strengthen their position in the market. For instance, in November 2015, Osiris Therapeutics, Inc. launched its new product Stravix. Stravix is a viable cryopreserved human placental tissue, and is a used in soft tissue repair therapies.

Moreover, increasing research and development activities around the world are expected to propel the stem cell therapy market growth. For instance, in December 2017, Mayo Clinic initiated the clinical phase I study on safety and feasibility of mesenchymal stem cells therapy in patients with recent intracerebral hemorrhage. This therapy is used for treating acute spontaneous hemorrhagic stroke. The study is expected to complete in December 2020.

Furthermore, In October 2017, University of California, San Francisco, U.S. initiated the clinical phase I study to evaluate the safety and efficacy of “In Utero Hematopoietic Stem Cell Transplantation” for treatment of fetuses with alpha thalassemia major. This  is a blood disorder which reduces production of hemoglobin. The study is expected to complete in February 2024.

Key Takeaways of the Stem Cell Therapy Market:

• The global stem cell therapy market is expected to witness a CAGR of 21.0% during the forecast period (2018 – 2026), owing to increasing research and development activities related to stem cell therapies for tissue regeneration.
• Among the regions, Asia Pacific is expected hold the largest market share, owing to increasing product launches in the region. For instance, in May 2019, Sumitomo Dainippon Pharma Co., Ltd. (Headquarter- Osaka, Japan) launched a new product called RETHIO 100 mg I.V. infusion which is used in autologous hematopoietic stem cell transplantation for treating pediatric malignant solid tumors.

• Major players operating in the global stem cell therapy market include Osiris Therapeutics, Inc. Novartis AG, GlaxoSmithKline Plc., MEDIPOST Co., Ltd., Anterogen Co., Ltd. Pharmicell Co., Ltd. Holostem Terapie Avanzate S.r.l. JCR Pharmaceuticals Co., Ltd. NuVasive, Inc. RTI Surgical, Inc., and  Fibrocell Science, Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, 
#3200 
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]